# Q2(R2) Validation of Analytical Procedures - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/q2r2-validation-of-analytical-procedures/2fb8b117-5251-4360-87db-a581ceb120a0

> FDA guidance document: Q2(R2) Validation of Analytical Procedures. Issue date: March 06, 2024. Get complete insights and analysis.

---

## Details

- Title: Q2(R2) Validation of Analytical Procedures
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-03-06
- Last Changed: 2024-03-07
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-1503">FDA-2022-D-1503</a>

## Related Documents

- [Q14 Analytical Procedure Development](https://www.globalkeysolutions.net/guidances/guidance-document/q14-analytical-procedure-development/7f445a67-e90c-4c67-a0c6-958d21e1d405)
- [M12 Drug Interaction Studies](https://www.globalkeysolutions.net/guidances/guidance-document/m12-drug-interaction-studies/2ca5aef5-80cc-464b-ba2c-bd69d35dfc2d)
- [Bacterial Vaginosis: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bacterial-vaginosis-developing-drugs-for-treatment-guidance-for-industry/d280b63f-a1bf-46b4-aa9d-41f650dd1b70)